Results 251 to 260 of about 227,935 (279)

Lucentis excluded from WHO list of essential medicines

BMJ, 2015
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug ...
openaire   +1 more source

Essential medicines lists are for high income countries too

BMJ, 2023
Petra, Brhlikova, Nav, Persaud, Claudia Garcia Serpa, Osorio-de-Castro, Allyson M, Pollock   +3 more
openaire   +2 more sources

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Javier Cortes, Giuseppe Curigliano, Carlos Barrios   +2 more
exaly  

Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward

The Lancet Global Health, 2022
Kristina Jenei, Elisabeth G E De Vries, Andrè M Ilbawi   +2 more
exaly  

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool

Pharmaceutics, 2022
Jennifer Walsh
exaly  

Developing an essential medicines list for livestock

Veterinary Record, 2021
openaire   +1 more source

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey

Lancet Oncology, The, 2021
Adam M Fundytus, Manju Sengar, Dorothy C Lombe   +2 more
exaly  

Essential medicines list in national cancer control plans: a secondary analysis from a global study

Lancet Oncology, The, 2022
Yehoda M Martei, Nazik Hammad, Ourania Dafni   +2 more
exaly  

WHO Essential Medicines List for Children

Pediatric Drugs, 2011
openaire   +2 more sources

WHO updates its Essential Medicines List

PharmacoEconomics & Outcomes News, 2017
openaire   +1 more source